Emily Liu

Emily Liu is a skilled professional with expertise in various fields of biomedical research, including Cell Biology, Molecular Biology, Immunology, Cancer Genomics, and Oncology.

She has a strong background in conducting research related to drug development, compound screening, and assay development, aiming to provide innovative solutions for patient care.

Emily Liu's educational background includes a Postdoctoral Scholar in Oncology and Cancer Biology from Stanford University, a Ph.D. in Cancer Biology and Immunology from Peking Union Medical College, and a Doctor of Medicine from Nankai University.

She has held key positions in reputable organizations, serving as the Director of Research at AccuraGen, and previously as the Director of R&D at Vortex Biosciences, Inc., Lead Scientist at Vortex Biosciences, Inc., VP of R&D at CVI Pharmaceuticals Inc., and more.

Emily's professional skills encompass a wide range of molecular biology techniques such as DNA extraction, PCR, next-generation sequencing, and mutagenesis, along with expertise in cell biology, immunology, and data analysis including tools like Python.

Passionate about developing novel drugs and non-invasive diagnostic technologies, Emily Liu is focused on early diagnosis, prognosis, and personalized treatment for patients.